- Home
- SILO vs PSTV Comparison
SILO vs PSTV Comparison
Compare SILO & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- PSTV
- Stock Information
- Founded
- SILO 2010
- PSTV 1996
- Country
- SILO United States
- PSTV United States
- Employees
- SILO N/A
- PSTV N/A
- Industry
- SILO Apparel
- PSTV Medical/Dental Instruments
- Sector
- SILO Consumer Discretionary
- PSTV Health Care
- Exchange
- SILO Nasdaq
- PSTV Nasdaq
- Market Cap
- SILO 8.8M
- PSTV 7.1M
- IPO Year
- SILO N/A
- PSTV N/A
- Fundamental
- Price
- SILO $1.35
- PSTV $1.20
- Analyst Decision
- SILO
- PSTV Strong Buy
- Analyst Count
- SILO 0
- PSTV 2
- Target Price
- SILO N/A
- PSTV $13.50
- AVG Volume (30 Days)
- SILO 228.4K
- PSTV 33.2K
- Earning Date
- SILO 03-04-2025
- PSTV 03-04-2025
- Dividend Yield
- SILO N/A
- PSTV N/A
- EPS Growth
- SILO N/A
- PSTV N/A
- EPS
- SILO N/A
- PSTV N/A
- Revenue
- SILO $72,102.00
- PSTV $5,725,000.00
- Revenue This Year
- SILO $1.86
- PSTV $32.12
- Revenue Next Year
- SILO N/A
- PSTV N/A
- P/E Ratio
- SILO N/A
- PSTV N/A
- Revenue Growth
- SILO N/A
- PSTV 52.63
- 52 Week Low
- SILO $0.77
- PSTV $0.93
- 52 Week High
- SILO $4.50
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- SILO 40.14
- PSTV 48.71
- Support Level
- SILO $1.39
- PSTV $1.18
- Resistance Level
- SILO $1.52
- PSTV $1.30
- Average True Range (ATR)
- SILO 0.14
- PSTV 0.09
- MACD
- SILO -0.05
- PSTV -0.00
- Stochastic Oscillator
- SILO 0.97
- PSTV 45.42
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).